Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Neurology Clinical Trials Market to reach USD 8.10 billion by the end of 2030.

Global Neurology Clinical Trials Market Size study & Forecast, by Phase (Phase I, Phase II, Phase III, Phase IV) by Study Design (Interventional, Observational, Expanded Access), by Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Others) and Regional Analysis, 2023-2030

Product Code: HLSMD-77826967
Publish Date: 20-05-2023
Page: 200

Global Neurology Clinical Trials Market is valued at approximately USD 5.24 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.6% over the forecast period 2023-2030. Neurology clinical trials are scientific studies conducted in humans to evaluate the safety and efficacy of new treatments, drugs, devices, or diagnostic procedures for neurological conditions. Neurological conditions are disorders that affect the brain, spinal cord and nerves that control movement, sensation, thinking, and behavior. The Neurology Clinical Trials Market is expanding because of factors such as the rising increasing prevalence of neurological diseases such as Alzheimer’s disease, epilepsy, and stroke and a growing number of clinical trials and research activities.

The growing prevalence of neurological disorders across the globe is fostering market growth. According to a report from Alzheimer Disease International Organization, in the year 2020, globally there were around 55 million people suffering from dementia and this figure is expected to reach 78 million in the year 2030 and 139 million by the year 2050. Furthermore, the rising number of neurological clinical trials activities is further driving the market growth, According to the Alzheimer’s Association article “Alzheimer’s Disease Drug Development Pipeline: 2021”, There were 121 drugs in clinical trials to treat Alzheimer’s disease, 39 Phase 3 trials are using 29 agents, 73 Phase 2 trials involving 65 agents, and 27 Phase 1 trial including 27 agents. Twelve medicines are now undergoing clinical trials with the goal of improving cognition, and 12 others are meant to treat behavioral and neuropsychiatric problems. As of February 2020, 97 drugs were undergoing studies to modify illness. Along with these, ClinicalTrials.gov reports that as of June 2022, there are 1,755 epilepsy studies in progress. Thus, the rising number of clinical trials activities is driving the market growth. In Addition, increasing funding for neurological studies by public organizations and a significant number of CROs providing neurology clinical research services is creating a lucrative opportunity for the market. However, the high cost of Neurology Clinical Trials stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Neurology Clinical Trials Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, rising FDA approvals for clinical trials, and the rising prevalence of neurological disorders in the region. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the rising prevalence of neurological conditions, an increase in the number of collaborations for clinical trials, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:
Supernus Pharmaceuticals, Inc. (Adamas Pharmaceuticals)
Novartis AG
Eisai Co., Ltd.
Eli Lilly and Company
Aurora Health Care
AbbVie Inc.
Zydus Group
Athira Pharma, Inc.
Annovis Bio Inc.

Recent Developments in the Market:
Ø In January 2023, Biogen Inc. entered into an agreement with Alcyone Therapeutics (Alcyone) to develop Alcyone’s ThecaFlex DRx™ System, an implantable medical device for the subcutaneous delivery of antisense oligonucleotide (ASO) therapeutics into the intrathecal space. Through this agreement, Biogen intends to make better use of the ThecaFlex DRxTM System to increase accessibility and the patient treatment experience for a larger population of people with neurological disorders such as spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS).
Ø In April 2022, Labcorp, announced the collaboration with Xcell Biosciences. The agreement states that Labcorp and Xcellbio will work together on initiatives to increase the effectiveness and security of cell and gene therapies for conditions such as Parkinson’s disease, cancer, and other illnesses.

Global Neurology Clinical Trials Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Phase, Study Design, Indication, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Phaseofferings of key players. The detailed segments and sub-segment of the market are explained below:

By Phase:
Phase I
Phase II
Phase III
Phase IV

By Study Design:
Expanded Access

By Indication:
Parkinson’s Disease (PD)
Huntington’s Disease
Traumatic Brain Injury (TBI)

By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Neurology Clinical Trials Market, by Region, 2020-2030 (USD Billion)
1.2.2. Neurology Clinical Trials Market, by Phase, 2020-2030 (USD Billion)
1.2.3. Neurology Clinical Trials Market, by Study Design, 2020-2030 (USD Billion)
1.2.4. Neurology Clinical Trials Market, by Indication, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Neurology Clinical Trials Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Neurology Clinical Trials Market Dynamics
3.1. Neurology Clinical Trials Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Increasing prevalence of neurological diseases such as Alzheimer’s disease, epilepsy, and stroke Growing number of clinical trials and research activities
3.1.2. Market Challenges High Cost of Neurology Clinical Trials
3.1.3. Market Opportunities Increasing funding for neurological studies by public organizations Significant number of CROs providing neurology clinical research services
Chapter 4. Global Neurology Clinical Trials Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Neurology Clinical Trials Market, by Phase
5.1. Market Snapshot
5.2. Global Neurology Clinical Trials Market by Phase, Performance – Potential Analysis
5.3. Global Neurology Clinical Trials Market Estimates & Forecasts by Phase 2020-2030 (USD Billion)
5.4. Neurology Clinical Trials Market, Sub Segment Analysis
5.4.1. Phase I
5.4.2. Phase II
5.4.3. Phase III
5.4.4. Phase IV
Chapter 6. Global Neurology Clinical Trials Market, by Study Design
6.1. Market Snapshot
6.2. Global Neurology Clinical Trials Market by Study Design, Performance – Potential Analysis
6.3. Global Neurology Clinical Trials Market Estimates & Forecasts by Study Design 2020-2030 (USD Billion)
6.4. Neurology Clinical Trials Market, Sub Segment Analysis
6.4.1. Interventional
6.4.2. Observational
6.4.3. Expanded Access
Chapter 7. Global Neurology Clinical Trials Market, by Indication
7.1. Market Snapshot
7.2. Global Neurology Clinical Trials Market by Indication, Performance – Potential Analysis
7.3. Global Neurology Clinical Trials Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
7.4. Neurology Clinical Trials Market, Sub Segment Analysis
7.4.1. Epilepsy
7.4.2. Parkinson’s Disease (PD)
7.4.3. Huntington’s Disease
7.4.4. Stroke
7.4.5. Traumatic Brain Injury (TBI)
7.4.6. Others
Chapter 8. Global Neurology Clinical Trials Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Neurology Clinical Trials Market, Regional Market Snapshot
8.4. North America Neurology Clinical Trials Market
8.4.1. U.S. Neurology Clinical Trials Market Phase breakdown estimates & forecasts, 2020-2030 Study Design breakdown estimates & forecasts, 2020-2030 Indication breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Neurology Clinical Trials Market
8.5. Europe Neurology Clinical Trials Market Snapshot
8.5.1. U.K. Neurology Clinical Trials Market
8.5.2. Germany Neurology Clinical Trials Market
8.5.3. France Neurology Clinical Trials Market
8.5.4. Spain Neurology Clinical Trials Market
8.5.5. Italy Neurology Clinical Trials Market
8.5.6. Rest of Europe Neurology Clinical Trials Market
8.6. Asia-Pacific Neurology Clinical Trials Market Snapshot
8.6.1. China Neurology Clinical Trials Market
8.6.2. India Neurology Clinical Trials Market
8.6.3. Japan Neurology Clinical Trials Market
8.6.4. Australia Neurology Clinical Trials Market
8.6.5. South Korea Neurology Clinical Trials Market
8.6.6. Rest of Asia Pacific Neurology Clinical Trials Market
8.7. Latin America Neurology Clinical Trials Market Snapshot
8.7.1. Brazil Neurology Clinical Trials Market
8.7.2. Mexico Neurology Clinical Trials Market
8.8. Middle East & Africa Neurology Clinical Trials Market
8.8.1. Saudi Arabia Neurology Clinical Trials Market
8.8.2. South Africa Neurology Clinical Trials Market
8.8.3. Rest of Middle East & Africa Neurology Clinical Trials Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Supernus Pharmaceuticals, Inc. (Adamas Pharmaceuticals) Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
9.3.2. AstraZeneca
9.3.3. Novartis AG
9.3.4. Eisai Co., Ltd.
9.3.5. Eli Lilly and Company
9.3.6. Aurora Health Care
9.3.7. AbbVie Inc.
9.3.8. Zydus Group
9.3.9. Athira Pharma, Inc.
9.3.10. Annovis Bio Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now